Mark M. Awad

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Mark M. Awad
Oct 11, 2024, 14:37 | Insight
U.S. FDA approved nivolumab with platinum-doublet chemotherapy
Toni Choueiri shared a post on X: "JUST IN: US_FDA approved nivolumab with platinum-doublet chemotherapy…
Oct 9, 2024, 16:38 | Blog
Stephen V Liu: Case report of MET mediating resistance to entrectinib in ROS1 NSCLC
Stephen V Liu shared a post on X: "Case report of MET mediating resistance to entrectinib…
Oct 4, 2024, 06:03 | Drugs
FDA approved Neoadjuvant/Adjuvant Nivolumab for resectable NSCLC
FDA Approval Introduces New Treatment Options for Adults with Resectable Lung Cancer Lacking Key Genetic…
Sep 6, 2024, 13:28 | Insight
Biagio Ricciuti: How adaptive mechanisms and increased GTP loading confer resistance to KRAS G12C OFF
Biagio Ricciuti shared on X: “Our in Nature Communications our collaborative effort showing how adaptive mechanisms…
Sep 2, 2024, 13:49 | Insight
Article of the day, September 2nd, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 18, 2024, 06:12 | Blog
Biagio Ricciuti: KEAPness signature outperforms deleterious KEAP1 mutations in predicting ICI efficacy in NSCLC
Biagio Ricciuti shared on X: "Sharing our latest effort out in Clinical Cancer Research! This multicenter…
Jul 9, 2024, 07:10 | Insight
10 Papers Suggested By Wafik S. El-Deiry on July 9
Wafik S. El-Deiry, Director of the Legorreta Cancer Center of Brown University and Associate Dean for…
Jun 21, 2024, 04:15 | Insight
Biagio Ricciuti: Fusion partners and chromosomal breakpoints of oncogenic fusions are not stochastic
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
May 18, 2024, 09:06 | Blog
Jarushka Naidoo: Perioperative Nivolumab in Stage IIA-IIIB NSCLC
Jarushka Naidoo shared on X/Twitter: ''Ph III CM77T trial at NEJM: Perioperative Nivolumab in Stage…
May 18, 2024, 08:33 | Blog
Rami Manochakian: Results of Checkmate 77T trial of
Rami Manochakian shared a post on X/Twitter: ''Hot Off The Press. Just published at NEJM.…
All: 10 Posts: 1 - 100
Special Coverage